The emerging approach of tirzepatide peptide represents a significant advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – GLP-1 and GIP – https://tirzepatide-peptide343988.elbloglibre.com/42430127/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment